These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37947373)

  • 1. COVID-19-associated liver injury: Adding fuel to the flame.
    Wang Y; Shen M; Li Y; Shao J; Zhang F; Guo M; Zhang Z; Zheng S
    Cell Biochem Funct; 2023 Dec; 41(8):1076-1092. PubMed ID: 37947373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Cell to Symptoms: The Role of SARS-CoV-2 Cytopathic Effects in the Pathogenesis of COVID-19 and Long COVID.
    Gonzalez-Garcia P; Fiorillo Moreno O; Zarate Peñata E; Calderon-Villalba A; Pacheco Lugo L; Acosta Hoyos A; Villarreal Camacho JL; Navarro Quiroz R; Pacheco Londoño L; Aroca Martinez G; Moares N; Gabucio A; Fernandez-Ponce C; Garcia-Cozar F; Navarro Quiroz E
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State.
    Domovitz T; Ayoub S; Werbner M; Alter J; Izhaki Tavor L; Yahalom-Ronen Y; Tikhonov E; Meirson T; Maman Y; Paran N; Israely T; Dessau M; Gal-Tanamy M
    Microbiol Spectr; 2022 Dec; 10(6):e0115022. PubMed ID: 36314945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroidal Angiotensin-Converting Enzyme 2 Protein Expression and Thyroid Function Tests in Patients with COVID-19: Results from a Retrospective Case Series and a Prospective Cohort Study.
    Koehler VF; Knösel T; Hasmann SE; Scherer C; Hellmuth JC; Muenchhoff M; Munker SM; Hoster E; Ladurner R; Spitzweg C
    Thyroid; 2023 Feb; 33(2):177-185. PubMed ID: 36453232
    [No Abstract]   [Full Text] [Related]  

  • 8. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.
    Robinson FA; Mihealsick RP; Wagener BM; Hanna P; Poston MD; Efimov IR; Shivkumar K; Hoover DB
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1059-H1068. PubMed ID: 33036546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.
    Amraei R; Rahimi N
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature.
    Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
    Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
    Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages.
    Hönzke K; Obermayer B; Mache C; Fatykhova D; Kessler M; Dökel S; Wyler E; Baumgardt M; Löwa A; Hoffmann K; Graff P; Schulze J; Mieth M; Hellwig K; Demir Z; Biere B; Brunotte L; Mecate-Zambrano A; Bushe J; Dohmen M; Hinze C; Elezkurtaj S; Tönnies M; Bauer TT; Eggeling S; Tran HL; Schneider P; Neudecker J; Rückert JC; Schmidt-Ott KM; Busch J; Klauschen F; Horst D; Radbruch H; Radke J; Heppner F; Corman VM; Niemeyer D; Müller MA; Goffinet C; Mothes R; Pascual-Reguant A; Hauser AE; Beule D; Landthaler M; Ludwig S; Suttorp N; Witzenrath M; Gruber AD; Drosten C; Sander LE; Wolff T; Hippenstiel S; Hocke AC
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35728978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 and the cardiovascular system.
    Hafiane A
    Clin Chim Acta; 2020 Nov; 510():311-316. PubMed ID: 32681935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.